Sitting, inactivity increase death risk among cancer survivors
Jan 13, 2022
The risk for both all-cause and cancer-specific death increased for cancer survivors with a combination of prolonged sitting and inactivity.
Oropharyngeal cancer incidence, mortality up among U.S. men
Dec 23, 2021
Among men, the incidence of OPC increased nationally 2.7% per year, particularly among men ages 65 years and older and non-Hispanic white men (more than 3% per year).
Knowledge of high skin cancer risk might modify risky behaviors
Feb 08, 2022
According to a skin cancer risk calculator, the prevalence of high risk for melanoma was 33% in the older group.
Smartphones: ‘digital dementia’ contributor or cognitive memory aid?
By
Kimberly Bonvissuto
May 04, 2022
Smartphones: friend or foe? It depends on whom you ask. Recent studies on smartphone use have found that mobile technology either can contribute to cognitive impairment or help improve cognition.
Culture and cancer: A delicate balance
By
Lois A. Bowers
Jun 20, 2016
Ongoing research reminds us that not everyone will feel the same way we do when it comes to medical decisions.
PSA testing rates up in the U.S. after change in guidance
Dec 01, 2021
Prostate-specific antigen testing rates increased for men aged 40 to 89 years following the 2017 revision of USPSTF recommendation on screening.
E-noses promising for diagnosing cancer from exhaled breath
Jun 30, 2022
Electronic noses detect volatile organic compounds in exhaled breath to diagnose cancer.
Cancer survivors face transportation barriers to accessing care
Mar 30, 2022
More transportation barriers were seen among younger survivors than their cancer-free peers, while elderly respondents faced similar transportation burden regardless of cancer history.
New cancer drugs approved faster in U.S. than Europe
Jun 14, 2022
The FDA received licensing applications sooner and had shorter review times compared with the European Medicines Agency.
Culturally tailored program increases colonoscopy completion
Feb 07, 2022
The overall rate of colonoscopy completion was 85% in the Hispanic population; the reasons for cancellation and no-show included cost.